Cardiac Science Corporation develops, manufactures, and markets diagnostic and therapeutic cardiology devices and systems in North America, Europe, and Asia. Its cardiac monitoring products primarily include resting ECG systems that allow physicians to record and analyze patient ECG waveforms; cardiac stress testing systems to monitor and analyze the performance of the heart under stress; Holter monitoring systems to record and assess the performance of a patient’s heart; cardiac rehabilitation telemetry systems to monitor the patient’s heart rate, heart rhythm, and ECG waveform data during rehabilitation exercises; vital signs monitors to monitor noninvasive blood pressure, pulse rate, temperature, and oxygen saturation; and cardiology data management systems that automate the processing, storage, retrieval, and editing of electrocardiograms and other patient data. Cardiac Science Corporation also offers cardiac monitoring related products and supplies comprising lead wires and electrodes, and thermal chart paper, as well as an array of complementary products, such as temperature and blood pressure monitors, spirometers, and pulse oximeters. In addition, it provides defibrillation products consisting of public access automated external defibrillators (AEDs) that are deployed in various settings; professional AEDs for use by hospital personnel, medical professionals, and emergency medical technicians; traditional defibrillators that are positioned in hospitals at various locations; and defibrillation supplies and accessories, including replacement electrodes and batteries, training devices, wall cabinets, and carrying cases. Further, the company offers training, maintenance, and support services. Cardiac Science Corporation sells its products through its sales force, independent distributors, direct sales representatives, and third party distributors under the Burdick, Quinton, and Powerheart brand names. Cardiac Science Corporation was founded in 1953 and is headquartered in Bothell, Washington.

Cardica, Inc. designs and manufactures medical devices for cardiac and other surgical procedures based on its proprietary stapling and cutting technology. It designs and manufactures its automated anastomosis product line, the C-Port Distal Anastomosis systems and PAS-Port Proximal Anastomosis system to automate the joining of blood vessels for the coronary artery bypass graft (CABG) surgery market. The company develops the C-Port Flex A Anastomosis system to enable automated anastomoses, or the joining of blood vessels, to be performed as part of minimally invasive and surgical robot-facilitated CABG procedures. In addition, Cardica is developing the Microcutter, a true multi-fire endoscopic stapling device designed to be used in a various procedures, including bariatric, thoracic, and general surgery. Cardica, Inc. was founded in 1997 and is based in Redwood City, California.

Cardinal Health Medical distributes health care supplies to hospitals, laboratories, doctors' offices, and other health care-related entities in the US and Canada. Working from more than 40 warehouses, it offers a broad range of surgical instruments, medical equipment, furniture, gloves, gowns, lab containers, syringes, and skin-care and respiratory care products. The medical supply division also provides logistics and cost-control solutions, makes a line of medical textile supplies, and assembles and distributes sterile and non-sterile Presource kits for medical and surgical procedures. Part of Cardinal Health, the division works side-by-side with the Cardinal Health Pharmaceutical distribution unit.

CardioNet, Inc. provides ambulatory, continuous, and real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health in the United States. It focuses on diagnosing and monitoring cardiac arrhythmias or heart rhythm disorders. The company offers Mobile Cardiac Outpatient Telemetry (MCOT) device that incorporates a patient-worn sensor attached to leads, which captures electrocardiogram (ECG) data and communicates wirelessly with a compact monitor that analyzes incoming information by applying proprietary algorithms designed to detect arrhythmias and eliminate data noise. Its MCOT device automatically transmits the ECG data to the CardioNet Monitoring Center, when the monitor detects an arrhythmic event. CardioNet also provides event monitoring services to record and store approximately 540 seconds of ECG signal; Holter monitoring services that store an image of the electrical impulses of every heartbeat or irregularity in either digital format on an internal compact flashcard or in analog format on a standard cassette tape located inside the monitor. In addition, it offers pacemaker monitoring services. CardioNet, Inc. markets its arrhythmia monitoring solutions, including the MCOT, primarily to cardiologists and electrophysiologists. CardioNet, Inc. has a strategic alliance with MedApps, Inc. CardioNet, Inc. was incorporated in 1994 and is headquartered in Conshohocken, Pennsylvania.

CareFusion Corporation, a medical technology company, provides various healthcare products and services in the United States and internationally. It operates in two segments, Critical Care Technologies, and Medical Technologies and Services. The Critical Care Technologies segment develops, manufactures, and markets equipment and related supplies for infusion, medication and supply dispensing, and respiratory care products. Its products include intravenous medication safety and infusion therapy delivery systems comprising disposables, software applications, and related patient monitoring equipment; automated dispensing machines and related applications for distributing and managing medication and medical supplies; and equipment and supplies for ventilation, and respiratory and sleep diagnostics. The Medical Technologies and Services segment develops, manufactures, and markets disposable infection prevention products, software-based infection detection services, surgical and diagnostic instrumentation, and neurological monitoring equipment. It offers skin disinfectant and other patient-preparation products, hair-removal and skin-care products, infection detection software, and custom surgical procedure kits; surgical instruments and related products and services, and interventional specialty products, such as diagnostic trays and biopsy needles, drainage catheters and vertebral augmentation products, and neurological monitoring and diagnostic products. CareFusion Corporation serves hospitals and other healthcare facilities comprising oncology clinics, ambulatory surgical centers, clinics, long-term care facilities, and physician offices. CareFusion Corporation sells its products and services through a combination of direct sales representatives and third-party distributors. CareFusion Corporation is headquartered in San Diego, California.

CAS Medical Systems, Inc. develops and manufactures medical devices for non-invasive patient monitoring. The company’s FORE-SIGHT Absolute Cerebral Oximeter is a cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for all patients, regardless of age or weight. This information helps avert brain damage or death during surgery and in critical care situations by allowing clinicians to identify patients with dangerously low levels of cerebral oxygen and intervene to reverse the condition. CAS Medical Systems’ product lines include the high-acuity monitoring capabilities of the FORE-SIGHT Cerebral Oximeter; and MAXNIBP, a proprietary non-invasive blood pressure measurement technology. The company also offers a line of bedside vital signs monitoring products, and supplies and service, including blood pressure cuffs and products for neonatal intensive care. CAS Medical Systems markets its products through its own sales force, distributors, and manufacturers representatives, as well as through hospital, alternate site, homecare, veterinary, and emergency medical distribution channels. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.

CCS Medical Holdings, Inc. emerged from Chapter 11 bankruptcy protection in 2010. CCS Medical Holdings knows that doorstep delivery is just a convenience for many, but it's critical for patients with chronic conditions. The company provides mail-order delivery of medical supplies to treat diabetes, as well as chronic wounds, incontinence, respiratory ailments, and other illnesses. CCS distributes a variety of drugs and medical supplies including blood glucose meters, catheters, insulin pumps, nebulizers, and ostomy and wound care supplies. It is one of the largest providers of respiratory medications and diabetes testing supplies to Medicare customers.

China Medical Technologies, Inc. (the "Company") is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products using Enhanced Chemiluminescence ("ECLIA") technology, Fluorescent in situ Hybridization ("FISH") technology and Surface Plasmon Resonance (“SPR”) technology to detect and monitor various diseases and disorders. China Medical Technologies was listed on the Nasdaq Global Select Market on August 10, 2005 and trades under the ticker "CMED". ECLIA is operated through our wholly-owned subsidiary Beijing Yuande Bio-Medical Engineering Co., Ltd. ("Yuande") in China. Yuande was established in 1999 and its headquarters and manufacturing facilities are located in the Beijing Economic-Technological Development Area. The Company was awarded ISO 9001 certification and ISO 13485:2003 certification in 2006.Our first ECLIA analyzers and reagents were launched in 2004. In light of the Company's extensive research in chemiluminescence technology, we believe we are one of the first China-based companies to successfully develop the products and, more importantly, the first to offer an integrated platform including self-developed analyzers and reagents. We manufacture both the equipment and reagents that detect and monitor various diseases and disorders by analyzing blood through laboratory evaluation. FISH and SPR are operated through our other wholly-owned subsidiary, Beijing GP Medical Technologies, Ltd., which was established in 2006. We acquired our FISH business in March 2007 and launched our FISH-related products in the same year. We believe the FISH products will complement our existing ECLIA diagnostic products by providing proprietary tests for the diagnosis of prenatal and postnatal disorders as well as various cancers that arise from genetic mutations.

Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications. It offers Essure, a permanent birth control system for women. The Essure system delivers a micro-insert into a woman's fallopian tubes, causing benign tissue in-growth that blocks the fallopian tubes. The company distributes its products through direct sales force and distributor networks primarily to physicians and hospitals. It primarily operates in the United States, France, and the rest of Europe. Conceptus, Inc. was founded in 1992 and is headquartered in Mountain View, California.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings in the United States and internationally. The company’s Medical Devices segment provides endomechanical instruments, which include laparoscopic instruments and surgical staplers; soft tissue repair products, such as sutures, mesh, biosurgery products, and hernia mechanical devices; and energy devices, including vessel sealing, electrosurgical, and ablation products and related capital equipment. This segment also offers oximetry and monitoring products comprising sensors, monitors, and temperature management products; airway and ventilation products that include airway, ventilator, breathing systems, and inhalation therapy products; and vascular therapy and compression products. The company’s Pharmaceuticals segment provides branded and generic pharmaceuticals, such as pain and addiction treatment products; medicinal narcotics and acetaminophen; active pharmaceutical ingredients, including peptides, generic APIs, stearates and phosphates to the pharmaceutical industry; and specialty chemicals. It also offers contrast delivery systems and contrast agents; and radiopharmaceuticals, which include radioactive isotopes and associated pharmaceuticals. The company’s Medical Supplies segment provides nursing care products, such as incontinence, woundcare, enteral feeding, urology, and suction products; and medical surgical products that comprise operating room supply products and related accessories, electrodes, thermometry, and chart paper product lines. It also offers SharpSafety Products, which include needles, syringes, and sharps disposal products; and original equipment manufacturer products. Covidien serves hospitals, surgi-centers, and drug manufacturers, as well as alternate site facilities, including long-term care facilities and imaging centers. Covidien plc is based in Dublin, Ireland.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.